# Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent

> **NCT04321941** · PHASE2 · COMPLETED · sponsor: **Lument AB** · enrollment: 60 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DIAGNOSTIC_TEST:** Lumentin
- **DIAGNOSTIC_TEST:** Movprep

## Key facts

- **NCT ID:** NCT04321941
- **Lead sponsor:** Lument AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-29
- **Primary completion:** 2022-04-04
- **Final completion:** 2022-05-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321941, "Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04321941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*